BDZ-P7 inhibits AMPA receptor GluA2, GluA1/2, GluA2/3, and GluA1 subunit with IC50s of 3.03 µM, 3.14 µM, 3.19 µM, 3.2 µM. BDZ-P7 has neuroprotective effect and reinstates locomotor abilities in a mouse model of Parkinsons disease[1].
Molecular Weight:
377.82
Formula:
C19H20ClNO5
Target:
iGluR
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
